Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

In vivo antiangiogenic activity described for FMPA

Dec. 7, 1999

ImClone and Merck KGaA initiate first international phase III trial center of C225

Dec. 6, 1999

Maret initiates clinical development of MARstem for chemotherapy-induced neutropenia

Dec. 3, 1999

Foscan NDA accepted for review

Dec. 3, 1999

Liposomal vinorelbine: design and preliminary characterization in vitro and in vivo

Dec. 1, 1999

Eukarion awarded SBIR grant to develop treatment for radiation damage

Dec. 1, 1999

MMP inhibitor NF-681 targets renal cell carcinoma

Dec. 1, 1999

Team from P&G discovers new use for an old drug

Dec. 1, 1999

Efficacy of FXR-targeting therapy validated by Symphar-Ilex team

Dec. 1, 1999

3-DP investigators study role of MMP in tumor angiogenesis

Nov. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...